Michael Lawton

9.6k total citations · 2 hit papers
112 papers, 6.4k citations indexed

About

Michael Lawton is a scholar working on Neurology, Molecular Biology and Plant Science. According to data from OpenAlex, Michael Lawton has authored 112 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Neurology, 38 papers in Molecular Biology and 37 papers in Plant Science. Recurrent topics in Michael Lawton's work include Parkinson's Disease Mechanisms and Treatments (41 papers), Neurological disorders and treatments (23 papers) and Plant tissue culture and regeneration (15 papers). Michael Lawton is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (41 papers), Neurological disorders and treatments (23 papers) and Plant tissue culture and regeneration (15 papers). Michael Lawton collaborates with scholars based in United Kingdom, United States and Germany. Michael Lawton's co-authors include Christopher J. Lamb, Chris Lamb, Richard A. Dixon, Naohiro Kato, Eric Lam, José León, Ilya Raskin, Michel Dron, Yoav Ben‐Shlomo and Nasser Yalpani and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael Lawton

109 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Programmed cell death, mitochondria and the plant hypersensitive response

2001 712 citations Michael Lawton et al. profile →
Signals and transduction mechanisms for activation of plant defenses against microbial attack

1989 592 citations Michael Lawton et al. profile →

Peers

Countries citing papers authored by Michael Lawton

Since Specialization

Citations

This map shows the geographic impact of Michael Lawton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lawton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lawton more than expected).

Fields of papers citing papers by Michael Lawton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lawton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lawton. The network helps show where Michael Lawton may publish in the future.

Co-authorship network of co-authors of Michael Lawton

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lawton. A scholar is included among the top collaborators of Michael Lawton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lawton. Michael Lawton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cholinergic degeneration in prodromal and early Parkinson’s disease: a link to present and future disease states 2025 ·Brain ·(unknown), (unknown), (unknown), (unknown), Tanja Zerenner, Michael Lawton, Yoav Ben‐Shlomo, Ludovica Griffanti, (unknown), Johannes Klein	2
2	CRISPR activation: identifying and using novel genes for plant disease resistance breeding 2025 ·Frontiers in Genome Editing ·J. McLaughlin, (unknown), Michael Lawton, Rong Di	2
3	Systematic Review of Clinical Prediction Models for the Risk of Emergency Caesarean Births 2024 ·BJOG An International Journal of Obstetrics & Gynaecology ·(unknown), Laura Bonnett, Jon Heron, Michael Lawton, Gemma Clayton, Gordon C. S. Smith, Jane E. Norman, Louise C. Kenny, Debbie A. Lawlor, Abi Merriel, (unknown)	1
4	Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 Years 2024 ·Movement Disorders Clinical Practice ·(unknown), Tanja Zerenner, (unknown), Michael Lawton, Vicky Marshall, (unknown), Katherine A. Grosset, Huw R. Morris, (unknown), Yoav Ben‐Shlomo, Donald G. Grosset	9
5	Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose‐Driven Approach 2024 ·Movement Disorders ·Connie Marras, Seyed‐Mohammad Fereshtehnejad, Daniela Berg, Nicolaas I. Bohnen, Kathy Dujardin, Roberto Erro, Alberto J. Espay, Glenda M. Halliday, Jacobus J. van Hilten, (unknown), Beomseok Jeon, Christine Klein, Albert F.G. Leentjens, Brit Mollenhauer, Ronald B. Postuma, Mayela Rodríguez‐Violante, Tanya Simuni, Daniel Weintraub, Michael Lawton, Tiago Mestre	21
6	Is depression in those with Alzheimer’s Disease different to depression in those without dementia? 2023 ·Alzheimer s & Dementia ·Lindsey I. Sinclair, Michael Lawton, Jennifer C Palmer, Clive Ballard, (unknown)	1
7	Genome-wide Analysis of Motor Progression in Parkinson Disease 2023 ·Neurology Genetics ·Alejandro Martínez-Carrasco, Raquel Real, Michael Lawton, Regina H. Reynolds, Manuela Tan, (unknown), Nigel Williams, Camille Carroll, Jean‐Christophe Corvol, (unknown), Donald G. Grosset, John Hardy, Mina Ryten, Yoav Ben‐Shlomo, Maryam Shoai, Huw R. Morris	5
8	Treatment burden in multiple long-term conditions: a mixed-methods study protocol 2023 ·BJGP Open ·Rachel Johnson, (unknown), Thomas Blakeman, Maria Panagioti, Michael Lawton, Shoba Dawson, Polly Duncan, Simon Fraser, José M Valderas, (unknown), Rebecca Goulding, Chris Salisbury	1
9	Striatal Dopamine Loss in Early Parkinson's Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging 2023 ·Movement Disorders Clinical Practice ·(unknown), Naveed Malek, Michael Lawton, (unknown), (unknown), Katherine A. Grosset, Yoav Ben‐Shlomo, Donald G. Grosset	20
10	Association between the LRP1B and APOE loci and the development of Parkinson’s disease dementia 2022 ·Brain ·Raquel Real, Alejandro Martínez-Carrasco, Regina H. Reynolds, Michael Lawton, Manuela Tan, Maryam Shoai, Jean‐Christophe Corvol, Mina Ryten, Catherine Bresner, Leon Hubbard, Alexis Brice, Suzanne Lesage, Johann Faouzi, Alexis Elbaz, Fanny Artaud, Nigel Williams, (unknown), Yoav Ben‐Shlomo, Donald G. Grosset, John Hardy, Huw R. Morris	31
11	Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts 2022 ·Journal of Neurology Neurosurgery & Psychiatry ·Michael Lawton, Manuela Tan, Yoav Ben‐Shlomo, Fahd Baig, Thomas R. Barber, Johannes Klein, Samuel Evetts, (unknown), Naveed Malek, Katherine Grosset, Roger A. Barker, Nigel Williams, David J. Burn, Thomas Foltynie, Huw R. Morris, Nicholas Wood, Donald G. Grosset, (unknown)	10
12	Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson’s in an international setting 2022 ·BMJ Open ·Francesca Bowring, Jessica Welch, (unknown), Christine Lo, Michael Lawton, Patricia Sulzer, Anne-Marie Hanff, Rejko Krüger, Inga Liepelt‐Scarfone, (unknown)	5
13	Quantifying activities of daily living impairment in Parkinson’s disease using the Functional Activities Questionnaire 2021 ·Neurological Sciences ·Sara Becker, Claire Pauly, Michael Lawton, Géraldine Hipp, Francesca Bowring, Patricia Sulzer, (unknown), Rejko Krüger, Thomas Gasser, Inga Liepelt‐Scarfone	3
14	Cohort profile: the Oxford Parkinson’s Disease Centre Discovery Cohort MRI substudy (OPDC-MRI) 2020 ·BMJ Open ·Ludovica Griffanti, Johannes Klein, Konrad Szewczyk‐Królikowski, Ricarda Menke, Michal Rolinski, Thomas R. Barber, Michael Lawton, Samuel Evetts, (unknown), (unknown), (unknown), Richard Wade‐Martins, (unknown), Clare E. Mackay	12
15	The Diagnosis of Urinary Tract Infection in Young Children (DUTY) Study Clinical Rule: Economic Evaluation 2017 ·Value in Health ·William Hollingworth, John Busby, Christopher Butler, Kathryn O’Brien, Jonathan A C Sterne, Kerenza Hood, Paul Little, Michael Lawton, Kate Birnie, Emma Thomas‐Jones, Kim Harman, Alastair D Hay	9
16	Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease 2016 ·Movement Disorders ·Naveed Malek, Michael Lawton, Diane M.A. Swallow, Katherine A. Grosset, Sarah Marrinan, Nin Bajaj, Roger A. Barker, David J. Burn, John Hardy, Huw R. Morris, Nigel Williams, Nicholas Wood, Yoav Ben‐Shlomo, Donald G. Grosset	126
17	Parkinson’s Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery Cohort 2015 ·Journal of Parkinson s Disease ·Michael Lawton, Fahd Baig, Michal Rolinski, (unknown), Kannan Nithi, Margaret May, Yoav Ben‐Shlomo, (unknown)	79
18	Improving sugarcane for biofuel: engineering for an even better feedstock 2009 ·Global Change Biology ·(unknown), James M. Shine, Jorge A. da Silva, Michael Lawton, Stacy A. Bonos, Martín Calviño, Helaine Carrer, (unknown), Neil C. Glynn, (unknown), Jing Ma, (unknown), (unknown), Ray Ming	9
19	B-type natriuretic peptide predicts cardiac injury and dysfunction after subarachnoid hemorrhage 2003 ·Journal of the American College of Cardiology ·Poyee P. Tung, Alexander Kopelnik, (unknown), Michael Lawton, Daryl R. Gress, Barbara J. Drew, Elyse Foster, William J. Young, William W. Parmley, Jonathan G. Zaroff	2
20	Co-Expression of Calcium-Dependent Protein Kinase with the Inward Rectified Guard Cell K+ Channel KAT1 Alters Current Parameters in Xenopus laevis Oocytes 2000 ·Plant and Cell Physiology ·Gerald A. Berkowitz, Xinyan Zhang, Richard W. Mercier, Qiang Leng, Michael Lawton	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact